Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE:MTEC) (Frankfurt: 3CM), a leading digital cannabis education and business technology company, is pleased to announce it will be joining the Global Cannabis Partnership (GCP), a collective of leaders in the government-sanctioned, adult-use recreational cannabis industry, as a Member organization. The goal of the GCP is to develop an international standard for the safe and responsible production, distribution and consumption of legal recreational cannabis and help shape the face of social responsibility in the cannabis industry.

“The Global Cannabis Partnership has done an admirable job setting forth a vision to establish standards for informed cannabis usage and social responsibility across the cannabis industry, and we are pleased to join their esteemed network of agencies and organizations dedicated to elevating the sector’s commitment to CSR,” said Daniel Davidzon, Director of Strategy and Education, Cannvas MedTech Inc. “We look forward to working with the Global Cannabis Partnership to help Canadians curious about cannabis determine whether it’s beneficial to their lifestyle and learn more about its potential health benefits through Cannvas.Me, our free and unbiased evidence-backed cannabis education platform.”


Established in 2018, the Global Cannabis Partnership aims to develop an international initiative for the cannabis sector focused on establishing worldwide corporate social responsibility standards related to the production, marketing, public education, sale, after-sales service and informed consumption of legal adult-use recreational cannabis.

The GCP’s main objectives are to build credibility for government agencies, industry and partners through responsible practices, align and leverage common principles and practices across diverse jurisdictions, and help partners mitigate negative impacts and leverage best practices from within and outside the industry to protect and enhance social licence to operate, with a view to minimizing harm.

“We are excited to join the Global Cannabis Partnership and work with leading Canadian brands and respected government, financial and law institutions to help shape a more responsible cannabis landscape for active and potential consumers,” said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc. “We expect to play a major role within the GCP to help achieve our common goal of educating the public on all aspects of cannabis consumption and look forward to exploring other areas in which Cannvas can offer specialized support.”

Cannvas hopes to leverage the content and resources available through Cannvas.Me, its free and unbiased digital cannabis education platform, to help guide the Global Cannabis Partnership’s public education initiative to help consumers make informed decisions. Operating independent of any licensed producers or clinics and working with its own Medical Advisory Board and Educational Advisory Panel, Cannvas.Me provides a safe space for cannabis education with no pressure to purchase or consume.

Organizations who have joined the Global Cannabis Partnership to date encompass government agencies, licensed producers, national associations, industry partners and community groups from the global cannabis industry, including: Cannabis NB, Canopy Growth Corporation, Aphria, The Green Organic Dutchman, GreenStar Brands, High Park Company, Up Cannabis, MedReleaf, Cansortium Holdings, T4G, McCarthy Tétrault LLP, EY, PwC, Cannabis Compliance Inc., Civilized, Business of Cannabis, Revolution Strategy, Emblem Corp., HEXO Corp., Cannabis OneFive, Grant Thornton, Sundial, Maricann, Organigram and Zenabis.

Global Cannabis Partnership operations are managed by Revolution Strategy, a full-service communications agency based in New Brunswick, Canada, one of the country’s leading jurisdictions in the growing cannabis industry. The GCP is governed by an Advisory Board composed of founding member organizations. Lara Wood, General Manager, Cannabis New Brunswick is Chair in 2018-19, and Jeff Ryan, Vice President, Government and Stakeholder Relations is Vice-Chair for this time period.

About the Global Cannabis Partnership
Founded by Revolution Strategy, the Global Cannabis Partnership is a collaboration of leaders in the government-sanctioned, adult-use recreational cannabis industry. With representation from government, private-sector and affiliate organizations, the GCP is creating an international standard for the safe and responsible production, distribution and consumption of legal recreational cannabis. One of its first activities will be to create a Responsible Cannabis Framework, to shape the face of social responsibility in the recreational cannabis industry.

For additional information:
globalcannabispartnership.com

About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

For additional information:
www.cannvasmedtech.com

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.

SOURCE Cannvas MedTech Inc.

For further information: Media Contact: Pamela McKay, Senior Communications Director, Revolution Strategy, pamela@revolutionstrategy.com, 506-333-4466; Investor Relations: Renmark Financial Communications Inc., Shushu Feng: sfeng@renmarkfinancial.com, Tel: (416) 644-2020 or (212) 812-7680

Click here to connect with Cannvas MedTech (CSE:MTEC) for an Investor Presentation.

Source: www.newswire.ca

 Matica Enterprises Inc. (CSE: MMJ) (OTCQB: MMJFF) (FSE: 39N) (“Matica” or the “Company”) reports the Company has granted 6,500,000 stock options exercisable at $0.05 for five years from date of grant. These include 4,000,000 options to two officers (who are also directors) and, 2,500,000 to two consultants.

For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com.

Keep reading... Show less

The Company welcomes adult-use customers at its eight dispensaries across the state and will create 120 new jobs in surrounding communities

– Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced it will begin serving adult-use consumers across its eight dispensaries in Arizona .

Keep reading... Show less

Harvest Health & Recreation Inc. (“Harvest”) (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the launch of recreational cannabis sales in Arizona .

Keep reading... Show less

Jason Mitchell Co-Founder, Director and Chief Executive Officer, HempFusion Wellness Inc. (“HempFusion” or the “Company”) (TSX: CBD.U), and his team joined David Chelich Sector Head, Global Energy and Diversified Industries, TMX Group, to celebrate the Company’s new listing on Toronto Stock Exchange and open the market.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it is one of the seventeen companies in the U.S. and Canada that will be included in the First Psychedelics Exchange Traded Fund, which is managed by Horizons ETF Management.

The Horizons Psychedelic Stock Index ETF index is expected to start trading on Tuesday, January 26, under the ticker PSYK on the NEO exchange.

Keep reading... Show less